The estimated Net Worth of Carron Shmerling Lisa is at least $590 Tisíc dollars as of 8 February 2007. Carron Lisa owns over 11,250 units of Momenta Pharmaceuticals stock worth over $590,400 and over the last 18 years Carron sold MNTA stock worth over $0.
Carron has made over 1 trades of the Momenta Pharmaceuticals stock since 2007, according to the Form 4 filled with the SEC. Most recently Carron exercised 11,250 units of MNTA stock worth $94,613 on 8 February 2007.
The largest trade Carron's ever made was exercising 11,250 units of Momenta Pharmaceuticals stock on 8 February 2007 worth over $94,613. On average, Carron trades about 5,625 units every 0 days since 2007. As of 8 February 2007 Carron still owns at least 11,250 units of Momenta Pharmaceuticals stock.
You can see the complete history of Carron Lisa stock trades at the bottom of the page.
Carron's mailing address filed with the SEC is C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE, MA, 02142.
Over the last 20 years, insiders at Momenta Pharmaceuticals have traded over $110,027,424 worth of Momenta Pharmaceuticals stock and bought 827,300 units worth $5,505,611 . The most active insiders traders include Christoph H Westphal, Craig A Wheeler a Peter Barrett. On average, Momenta Pharmaceuticals executives and independent directors trade stock every 6 days with the average trade being worth of $448,442. The most recent stock trade was executed by Ian Fier on 20 August 2020, trading 1,808 units of MNTA stock currently worth $94,323.
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
Momenta Pharmaceuticals executives and other stock owners filed with the SEC include: